Saint-Priest-en-Jarez
Saint-Priest-en-Jarez
Saint-Priest-en-Jarez, Pays de la Loire Region, France8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Active, not recruiting | Phase 3 | 2026-10-01 | NCT04562389 | |
| Objective Assessment of Skin Damage Using ADHELASKIN in Patients With Systemic Sclerosis | Skin and Connective Tissue Diseases, connective tissue disorder, skin disorder, systemic sclerosis | Recruiting | Not applicable | 2026-07-31 | NCT07543679 | |
| Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Active, not recruiting | Phase 3 | 2026-07-14 | NCT05248646 | |
| DVT Burden and the Risk of Post-thrombotic Syndrome | Embolism and Thrombosis, Postthrombotic Syndrome, Venous Thrombosis, cardiovascular disorder, thrombotic disease, vascular disorder, venous insufficiency | Recruiting | Not applicable | 2026-07-07 | NCT06385353 | |
| Impact of Endotest on Patients' Quality of Life: a Cohort Study | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, disease, endometriosis, female reproductive system disorder | Recruiting | Not stated | 2026-05-26 | NCT07560852 | |
| A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) | HER2-Positive Primary Breast Cancer; Residual Invasive Breast Cancer | Active, not recruiting | Phase 3 | 2026-05-15 | NCT04622319 | |
| A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Active, not recruiting | Phase 3 | 2026-04-20 | NCT03762850 | |
| Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Recruiting | Not applicable | 2024-07-10 | NCT05866575 |